Feasibility, Acceptability and Effect of a Transdiagnostic Psychological Treatment for Anxiety and Depression in Youth.
A Transdiagnostic Psychological Treatment for Anxiety and Depression in Youth: Feasibility, Acceptability and Effect in a Clinical Open Trial in Primary Care
1 other identifier
interventional
40
1 country
2
Brief Summary
The goal of this open clinical trial is to try out and evaluate a relatively new transdiagnostic psychological treatment, Unified Protocol (UP-C/A), in group format for children and adolescents aged 7-17 years of age with anxiety and/or depression and their parents, in primary care. The therapists in the project will receive training and on-going supervision in UP-C/A. The main questions it aims to answer are:
- 1.What are the children's (patients) and parents experience of undergoing a transdiagnostic psychological treatment (UP-C/A) in primary care?
- 2.What are the therapists' experience of having carried out the treatment with a transdiagnostic psychological treatment (UP-C/A) in primary care?
- 3.To what extent do children and parents answer self-reports and clinician administered instruments regarding symptoms of anxiety, depression, function and quality of life?
- 4.To what extent do children and their parents complete the treatment and what is the dropout rate?
- 5.What does the distribution of diagnoses and co-morbidity look like for patients included in the study?
- 6.What is the treatment outcome with regard to emotion regulation, symptoms of anxiety, depression, function and quality of life? rated by patients, parents and therapists.
- 7.To what extent are any effects maintained at a 6-month follow-up?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2022
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 8, 2022
CompletedFirst Submitted
Initial submission to the registry
March 27, 2023
CompletedFirst Posted
Study publicly available on registry
April 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2024
CompletedFebruary 24, 2025
February 1, 2025
2.1 years
March 27, 2023
February 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Emotion Regulation Index for Children and Adolescents (ERICA)
A self-report that measures various aspects of emotion regulation with three subscales: 1: Emotional Control (lower scores indicate more emotional control); 2: Emotional Self-Awareness (higher scores indicate more emotional self-awareness); 3: Situational Responsiveness (higher scores indicate more situational responsiveness). 16 items in total. Some scores are reversed. Likert-type scale 1 to 5.
Change from pre intervention to treatment completion at 12 weeks and at a 6 month follow-up.
Secondary Outcomes (6)
Revised Children's Anxiety and Depression Scale (R-CADS)
Change from pre intervention to treatment completion at 12 weeks and at a 6 month follow-up.
The Strengths and difficulties questionnaire (SDQ)
Change from pre intervention to treatment completion at 12 weeks and at a 6 month follow-up.
Kidscreen-10 Index
Change from pre intervention to treatment completion at 12 weeks and at a 6 month follow-up.
Children's Global Assessment Scale (C-GAS).
Change from pre intervention to treatment completion at 12 weeks and at a 6 month follow-up.
Client Satisfaction Questionnaire (CSQ-8)
After treatment completion at 12 weeks.
- +1 more secondary outcomes
Study Arms (1)
Unified Protocol (UP-C/A) for children and youth with anxiety disorders and/or depression
EXPERIMENTALA within group design where one clinical manualised intervention, the Unified protocol based on the third-wave of Cognitive Behavior Therapy (CBT), is offered in a 11 session group format to children and adolescents. Parent training is at the same time also offered in a group format. Therapists are trained in the method and receive regular supervision adhering to the evidence-based manual. The group treatment and parent training is delivered face-to- face.
Interventions
A transdiagnostic psychological group treatment, Unified Protocol (UP-C/A), one intervention, is tested for children and youth with anxiety disorders and/or depression seeking help in routine care in two primary care locations. Parents are at the same time offered parent training in a group format coupled with the module the children are working on. Feasibility, acceptability and effect of the intervention will be studied, with child self-report, parent-report and therapist assessment.
Eligibility Criteria
You may qualify if:
- Age 7-17 years of age
- Anxiety syndrome, obsessive-compulsive disorder and/or depression according to the Diagnostic and Statistical Manual of Mental disorders (DSM) as primary problem
- Patients and parents master the Swedish language without interpreter support.
- Willingness/ability to participate after receiving information about what participation entails
- In case of medication, this is on a stable dose, since six weeks
You may not qualify if:
- Psychosis, bipolar disorder. substance use syndrome, severely suicidal or pervasive developmental disorder
- Ongoing other psychological treatment
- Abuse or domestic violence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Liljeholmens Vårdcentral
Stockholm, 11794, Sweden
Älvsjö Vårdcental
Stockholm, Älvsjö, 12531, Sweden
Study Officials
- PRINCIPAL INVESTIGATOR
Lena Reuterskiöld, PhD
Region Stockholm
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 27, 2023
First Posted
April 25, 2023
Study Start
August 8, 2022
Primary Completion
August 28, 2024
Study Completion
October 30, 2024
Last Updated
February 24, 2025
Record last verified: 2025-02